MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Haemonetics taps outgoing Covidien CFO Dockendorff for board | Personnel Moves

Haemonetics taps outgoing Covidien CFO Dockendorff for board | Personnel Moves

By

Haemonetics taps outgoing Covidien CFO Dockendorff for board | Personnel Moves

Haemonetics (NYSE:HAE) added the outgoing CFO of Covidien (NYSE:COV), Charles Dockendorff, to its board of directors and said another director is stepping down to focus on his CEO duties.

Dockendorff has been the finance chief at Mansfield, Mass.-based Covidien since 1995.

Early this year Dockendorff announced plans to step down at the end of 2014 after a 25-year run in the companies that evolved into Covidien. He joined Kendall Healthcare Products, the foundation of Covidien formerly known as Tyco Healthcare, in 1989 as controller and was named vice president and controller in 1994, according to a press release.

"Chuck is a highly-respected healthcare industry leader.  He brings an extensive financial management and planning background to our board, along with considerable experience with one of the world’s premier healthcare products companies. His contributions will help to guide the company as it seeks to grow market share and provide industry leading returns to shareholders,"Haemonetics chairman Richard Meelia– himself a Covidien veteran who retired as CEO in 2011 – said in prepared remarks.

"Blood management is a key element of the health care continuum globally, as patient care advances and the focus on reducing costs continues to be a priority. Haemonetics is very well positioned with solutions to help our collection and hospital customers address these opportunities," Dockendorff added. "I look forward to joining the Board of Directors and serving the company’s shareholders."

Haemonetics also said that Paul Black resigned from its board effective July 31, "based on his desire to focus more of his time in his role" as president & CEO of Allscripts (NSDQ:MDRX)," according to a regulatory filing.

 Invacare CEO Blouch to retire

Invacare (NYSE:IVC)
said president & CEO Gerald Blouch is slated to retire July 31, succeeded on an interim basis by CFO Robert Gudbranson while the company searches for a permanent replacement.
Read more

 VirtualScopics makes interim CEO Converse permanent
VirtualScopics (NSDQ:VSCP) said last week that it named Eric Converse, interim president & CEO for the past 9 months, as its permanent chief executive.
Read more

 MDSave taps Stryker, Boston Scientific vet Magee
MDSave said it named former Stryker (NYSE:SYK) and Boston Scientific (NYSE:BSX) sales manager Calvin Magee as its new executive vice president and named Magee to its board of directors.
Read more

 Feldbaum replaces Burrill as Life Sciences Foundation chairman
The Life Sciences Foundation said it appointed Carl Feldbaum as its new interim chairman, replacing prominent venture capitalist Stephen Burrill, who helped form the organization. Burrill is under a cloud after the manager of 1 of his funds allegedly discovered that he and his company’s chief counsel and its CFO misappropriated nearly $20 million from the fund.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • A closer look at a microrobot that could treat a rare brain malformation
    Los Angeles–based startup Bionaut Labs emerged from stealth mode earlier this year to announce its intent to use drug-filled microrobots to treat certain cancers. The company has now secured a humanitarian use device designation from FDA to use a microrobot known as BNL-201 to treat Dandy-Walker syndrome, a rare brain malformation. In 1914, neurosurgeon Walter… […]
  • Heraeus buys Mo-Sci and ETS Technology Holdings
    The Heraeus Group has a deal to acquire Mo-Sci Corp. and ETS Technology Holdings, the Germany-based conglomerate announced this week. Mo-Sci is a supplier of glass microspheres, fibers and powders for medical devices, while ETS is the developer of bioactive glass fiber wound care product Mirragen, an FDA-cleared resorbable synthetic skin substitute. The companies —… […]
  • Medical Alley appoints new CEO
    The Medical Alley Association announced today that it appointed Roberta Dressen as its new president and CEO. Dressen takes over the position previously held by Shaye Mandle since 2014 before he announced his departure for the Biotechnology Innovation Organization (BIO) in February. Steffen Hovard served as interim CEO in the time since then. Get the full… […]
  • Westfall Technik names Mark Gomulka as CEO
    Westfall Technik’s board of directors has nominated Mark Gomulka to lead the company. Gomulka joined the Las Vegas–based plastics manufacturer as SVP in January 2020. Before that, he led Flex’s medical and precision plastics operations for five years and earlier spent 15 years at Nypro in various global operational and leadership roles. In those positions… […]
  • The MedTech Conference by AdvaMed to be a mixture of in-person and virtual
    To hold an event or not to hold a live event. Medtech trade association AdvaMed chose both for The Medtech Conference, which takes place next week. The September 27–30 conference includes a mixture of virtual presentations and in-person events in Washington, D.C., and Minneapolis. AdvaMed CEO Scott Whitaker mentioned several conference agenda highlights during a… […]
  • Varta launches online battery monitoring feature
    Battery maker Varta has launched a cloud computing feature to let customers remotely monitor battery charging, health and the temperature of the battery management system. While Varta makes microbatteries for medical devices such as hearing aids, the new online monitoring dashboard is meant for its “Easy Block” and “Easy Blade” modular smart batteries. The smart… […]
  • Bionaut Labs wins humanitarian use device designation to treat rare pediatric brain disorder
    Microrobotics startup Bionaut Labs has announced that FDA has granted a humanitarian use device designation for the device known as BNL-201 to treat Dandy-Walker syndrome, a congenital brain malformation affecting the cerebellum. According to the National Organization for Rare Disorders, the syndrome affects one out of every 25,000 to 35,000 live births. There are currently… […]
  • Integer plans $30 million innovation and manufacturing facility in Galway
    Integer Holdings Corp. (NYSE: ITGR) plans to build a medical device innovation and manufacturing facility in the Parkmore East area of Galway, Ireland. Plano, Texas–based Integer said the initial phase of the project will total 60,000 square feet and a $30 million investment over the coming years, with construction scheduled from 2022 to late 2023… […]
  • Accu-Tube appoints Matthew Haddle as CEO
    Accu-Tube today announced that it has appointed Matthew Haddle as its new CEO. Prior to joining the Englewood, Colorado-based company, Haddle was GM of industrial coating services and equipment at Praxair Surface Technology. He has also held senior management positions at Albany Engineered Composites and Accellent. Get the full story on our sister site, Medical… […]
  • LightDeck picks GS Plastic Optics for COVID-19 test ramp up
    LightDeck Diagnostics has selected GS Plastic Optics to make optical components for its new COVID-19 antibody testing platform. Boulder, Colorado–based LightDeck developed a screening platform to deliver results as quickly as five minutes for SARS-CoV-2 ultra-rapid antigen and COVID-19 total antibody tests, using a laser waveguide with a consumable cartridge for each testing sample.  Rochester,… […]
  • Hologic’s first Global Women’s Health Index flags preventative care for improvement
    An estimated 1.5 billion women have not been tested in the past year for critical diseases, according to Hologic’s first Global Women’s Health Index. On behalf of diagnostic maker Hologic, the Gallup World Poll surveyed more than 60,000 women and girls (age 15 and older) across the world to measure action and attitudes about women’s… […]

Leave a Reply